Radionuclides-hyaluronan-conjugate thromboresistant coatings to prevent in-stent restenosis

Biomaterials

Volumn 25, Issue 17, 2004, Pages 3895-3905

  Thierry, Benjamin ^a   Winnik, Françoise M ^b   Merhi, Yahye ^c   Silver, Jim ^d   Tabrizian, Maryam ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d Endovascular Division   (United States)

Author keywords

Catheter; Hemocompatibility; Hyaluronan; Restenosis; Stent; Surface modification

Indexed keywords

COATING TECHNIQUES; MATHEMATICAL MODELS; POLYTETRAFLUOROETHYLENES; RADIOISOTOPES; TISSUE; X RAY PHOTOELECTRON SPECTROSCOPY;

BRACHYTHERAPY; STENTS;

BIOMATERIALS;

FIBRINOGEN; HYALURONIC ACID; INDIUM; NICKEL; PENTETIC ACID; POLITEF; RADIOISOTOPE; TITANIUM; YTTRIUM;

ARTICLE; BRACHYTHERAPY; CATHETER; CELL PROLIFERATION; HYPERPLASIA; IRRADIATION; MASS SPECTROMETRY; METHODOLOGY; PRIORITY JOURNAL; RADIOTHERAPY; RESTENOSIS; REVASCULARIZATION; STENT; TIME; X RAY PHOTOELECTRON SPECTROSCOPY;

ADSORPTION; BLOOD VESSEL PROSTHESIS; BRACHYTHERAPY; COATED MATERIALS, BIOCOMPATIBLE; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FIBRINOGEN; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HYALURONIC ACID; MATERIALS TESTING; PENTETIC ACID; PROTEIN BINDING; RADIOISOTOPES; STENTS; SURFACE PROPERTIES;

EID: 1542328276     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.10.068     Document Type: Article

References (44)

1. Gershlick A.H. Role of stenting in coronary revascularisation. Heart. 86:2001;104-112.
2. Narins C.R., Ellis S.G. Prevention of in-stent restenosis. Semin Interv Cardiol. 3:1998;91-103.
3. Rensing B.J., Vos J., Smits P.C., Foley D.P., van den Brand M.J., van der Giessen W.J.et al. Coronary restenosis elimination with a sirolimus eluting stent. first European human experience with 6-month angiographic and intravascular ultrasonic follow-up Eur Heart J. 22:2001;2125-2130.
4. Heldman A.W., Cheng L., Jenkins G.M., Heller P.F., Kim D.W., Ware M. Jret al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 103:2001;2289-2295.
5. Fox R. American Heart Association 2001 scientific sessions. late-breaking science-drug-eluting stents Circulation. 104:2001;E9052.
6. Sousa J.E., Costa M.A., Abizaid A.C., Rensing B.J., Abizaid A.S., Tanajura L.F.et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. one-year angiographic and intravascular ultrasound follow-up Circulation. 104:2001;2007-2011.
7. Drachman D.E., Simon D.I. Restenosis. intracoronary brachytherapy Curr Treat Options Cardiovasc Med. 4:2002;109-118.
8. Elbert D.L., Herbert C.B., Hubbell J.A. Thin polymer layers formed by polyelectrolyte multilayer techniques on biological surfaces. Langmuir. 15:1999;5355-5362.
9. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis. the inhibit randomised controlled trial Lancet. 359:2002;551-557.
10. Bhargava B., Tripuraneni P. Role of intracoronary brachytherapy for in-stent restenosis? Lancet. 359:2002;543-544.
11. Sapirstein W., Zuckerman B., Dillard J. FDA approval of coronary-artery brachytherapy. N Engl J Med. 344:2001;297-299.
12. Liistro F., Gimelli G., Di Mario C., Nishida T., Montorfano M., Carlino M.et al. Late acute thrombosis after coronary brachytherapy. when is the risk over? Catheter Cardiovasc Interv. 54:2001;216-218.
13. Cheneau E., Waksman R., Yazdi H., Chan R., Fourdnadjiev J., Berzingi C. et al. How to fix the edge effect of catheter-based radiation therapy in stented arteries. Circulation. 106:2002;2271-2277.
14. Shih C.C., Lin S.J., Chen Y.L., Su Y.Y., Lai S.T., Wu G.J.et al. The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells. J Biomed Mater Res. 52:2000;395-403.
15. Lowe H.C., Oesterle S.N., Khachigian L.M. Coronary in-stent restenosis. current status and future strategies J Am Coll Cardiol. 39:2002;183-193.
16. Virmani R., Farb A., Kolodgie F.D. Histopathologic alterations after endovascular radiation and antiproliferative stents. similarities and differences Herz. 27:2002;1-6.
17. Petelenz B., Rajchel B., Bilski P., Misiak R., Bartyzel M., Wilczek K.et al. Physical and chemical limitations to preparation of beta radioactive stents by direct neutron activation. Biomaterials. 24:2003;427-433.
18. Serruys P.W., Kay I.P. I like the candy, I hate the wrapper. the (32)P radioactive stent Circulation. 101:2000;3-7.
19. Albiero R., Colombo A. European high-activity (32)P radioactive stent experience. J Invasive Cardiol. 12:2000;416-421.
20. Abatangelo G., Weigel P.H. Redefining hyaluronan. 2000;Elsevier, Amsterdam.
21. Verheye S., Markou C.P., Salame M.Y., Wan B., King 3rd S.B., Robinson K.A.et al. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol. 20:2000;1168-1172.
22. Morra M., Cassineli C. Non-fouling properties of polysaccharide-coated surfaces. J Biomater Sci Polym Ed. 10:1999;1107-1124.
23. Das T., Banerjee S., Samuel G., Sarma H.D., Ramamoorthy N., Pillai M.R. 188Re-ethylene dicysteine. a novel agent for possible use in endovascular radiation therapy Nucl Med Commun. 21:2000;939-945.
24. Hsieh B.T., Hsieh J.F., Tsai S.C., Lin W.Y., Huang H.T., Ting G.et al. Rhenium-188-labeled DTPA. a new radiopharmaceutical for intravascular radiation therapy Nucl Med Biol. 26:1999;967-972.
25. Gouin S., Winnik F.M. Quantitative assays of the amount of diethylenetriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetry. Bioconjug Chem. 12:2001;372-377.
26. ASTM F86. Standard practice for surface preparation and marking of metallic surgical implants. Annual Book of ASTM standards, Medical Devices and Services, vol. 13.01, American Society for Testing and Materials, 1995. p. 6-8.
27. McLean K.M., Johnson G., Chatelier R.C., Beumer G.J., Steele J.G., Griesser H.J. Method of immobilization of carboxymethyl-dextran affects resistance to tissue and cell colonization. Colloids Surf B Biointerfaces. 18:2000;221-234.
28. Thierry B., Merhi Y., Bilodeau L., Trépanier C., Tabrizian M. Nitinol versus stainless steel stents. acute thrombogenicity study in an ex vivo porcine model Biomaterials. 23:2002;2997-3005.
29. Gouin S, Valencia Grayeb MV, Winnik FM. Gadolinium diethylenetriamine pentaacetic acid/hyaluronan conjugates: preparation, properties and applications. In: Guiseppi-Elie A, Levon K, editors. Macromolecule-Metal Complexes, Macromolecular Symposia 186. Weinheim, Germany: Wiley-VCH; 2002. p. 105-10.
30. Nakajima N., Ikada Y. Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. Bioconjug Chem. 6:1995;123-130.
31. Brenda M., Doring R., Schernau U. Investigation of organic coatings and coating defects with the help of time-of-flight-secondary ion mass spectrometry (TOF-SIMS). Prog Org Coat. 35:1999;183-189.
32. Ruiz L., Hilborn J.G., Leonard D., Mathieu H.J. Synthesis, structure and surface dynamics of phosphorycholine functional biomimicking polymers. Biomaterials. 19:1998;987-998.
33. Belu A.M., Davies M.C., Newton J.M., Patel N. TOF-SIMS characterization and imaging of controlled-release drug delivery systems. Anal Chem. 72:2000;5625-5638.
34. Verin V., Popowski Y., de Bruyne B., Baumgart D., Sauerwein W., Lins M. et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med. 344:2001;243-249.
35. Wardeh A.J., Kay I.P., Sabate M., Coen V.L., Gijzel A.L., Ligthart J.M. et al. Beta-particle-emitting radioactive stent implantation. Safety Feasibility Study Circ. 100:1999;1684-1689.
36. Tepe G., Dinkelborg L.M., Brehme U., Muschick P., Noll B., Dietrich T.et al. Prophylaxis of restenosis with (186)Re-labeled stents in a rabbit model. Circulation. 104:2001;480-485.
37. Schulz C., Niederer C., Andres C., Herrmann R.A., Lin X., Henkelmann R. et al. Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis model. Circulation. 101:2000;1970-1975.
38. Fox R.A., Henson P.W. The dosimetry for a coronary artery stent coated with radioactive 188Re and 32P. Phys Med Biol. 45:2000;3643-3655.
39. McMurry T.J., Pippin C.G., Wu C., Deal K.A., Brechbiel M.W., Mirzadeh S.et al. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates. J Med Chem. 41:1998;3546-3549.
40. Wong J.Y.C., Chu D.Z., Yamauchi D.M., Williams L.E., Liu A., Wilczynski S.et al. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti- carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. Clin Cancer Res. 6:2000;3855-3863.
41. Cremonesi M., Ferrari M., Chinol M., Bartolomei M., Stabin M.G., Sacco E.et al. Dosimetry in radionuclide therapies with 90Y-conjugates. the IEO experience Q J Nucl Med. 44:2000;325-332.
42. Camera L., Kinuya S., Garmestani K., Wu C., Brechbiel M.W., Pai L.H.et al. Evaluation of the serum stability and in vivo biodistribution of CHX- DTPA and other ligands for yttrium labeling of monoclonal antibodies. J Nucl Med. 35:1994;882-889.
43. Morra M. On the molecular basis of fouling resistance. J Biomater Sci Polym Ed. 11:2000;547-569.
44. Albiero R., Adamian M., Kobayashi N., Amato A., Vaghetti M., Di Mario C.et al. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease. the Milan dose-response study Circulation. 101:2000;18-26.